Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T K Nordt

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Der Internist|June 13, 2001
[Thrombolytic therapy for acute myocardial infarct]T K Nordt, C Bode
Heart (British Cardiac Society)|November 5, 2003
Thrombolysis: newer thrombolytic agents and their role in clinical medicineT K Nordt, C Bode
Heart (British Cardiac Society)|May 17, 2005
Massive air embolism after MazeA Zirlik, T K Nordt
Seminars in Thrombosis and Hemostasis|December 29, 2000
Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approachesT K Nordt, C Bode
Zeitschrift Fur Kardiologie|May 8, 2000
[Endothelium and endogenous fibrinolysis]T K Nordt, C Bode
Zeitschrift Fur Kardiologie|September 22, 2001
[Optimal thrombolysis]T K Nordt, C Bode
Coronary Artery Disease|September 1, 1996
Clot-selective compared with nonselective fibrinolytic drugs: déjà vu--all over againB E Sobel, T K Nordt
Herz|May 15, 2001
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]T K Nordt, K Peter, C Bode
Herz|February 1, 1996
-Anticoagulation after intracoronary stent implantation-C Bode, T K Nordt, W Kübler
Thrombosis Research|September 25, 2001
Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesisT K Nordt, J Lohrmann, C Bode
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Der Internist|June 13, 2001
[Thrombolytic therapy for acute myocardial infarct]T K Nordt, C Bode
Heart (British Cardiac Society)|November 5, 2003
Thrombolysis: newer thrombolytic agents and their role in clinical medicineT K Nordt, C Bode
Heart (British Cardiac Society)|May 17, 2005
Massive air embolism after MazeA Zirlik, T K Nordt
Seminars in Thrombosis and Hemostasis|December 29, 2000
Impaired endogenous fibrinolysis in diabetes mellitus: mechanisms and therapeutic approachesT K Nordt, C Bode
Zeitschrift Fur Kardiologie|May 8, 2000
[Endothelium and endogenous fibrinolysis]T K Nordt, C Bode
Zeitschrift Fur Kardiologie|September 22, 2001
[Optimal thrombolysis]T K Nordt, C Bode
Coronary Artery Disease|September 1, 1996
Clot-selective compared with nonselective fibrinolytic drugs: déjà vu--all over againB E Sobel, T K Nordt
Herz|May 15, 2001
[GPIIb/IIIa blockers for optimizing thrombolysis in acute myocardial infarct]T K Nordt, K Peter, C Bode
Herz|February 1, 1996
-Anticoagulation after intracoronary stent implantation-C Bode, T K Nordt, W Kübler
Thrombosis Research|September 25, 2001
Regulation of PAI-1 expression by genetic polymorphisms. Impact on atherogenesisT K Nordt, J Lohrmann, C Bode
Pageof 4